Popular dog food recalled nationwide may contain sharp metal fragments, FDA says
The FDA has announced a nationwide recall of a popular canned dog food brand due to possible contamination with sharp metal fragments.
29 trends tracked about this subject — the full history, oldest to newest below.
The FDA has announced a nationwide recall of a popular canned dog food brand due to possible contamination with sharp metal fragments.
Sanofi's Sarclisa becomes the first cancer drug to receive FDA approval for delivery via an on-body injector.
The FDA has introduced a proposal to consolidate registration requirements for distributed drug manufacturing networks, aiming to increase supply chain transparency.
6 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
The FDA has issued a nationwide recall of 2.5 million bottles of eye drops following concerns over a potential foreign substance.
9 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
The FDA has approved Vera Therapeutics' dual-target drug, Trutakna, for the treatment of primary IgA nephropathy.
Publix is recalling frozen organic blueberries across eight states following 12 reports of E. coli contamination.
Tobacco companies are leveraging the surge in nicotine pouch popularity as consumers shift away from traditional cigarettes and vapes.
The U.S. sunscreen market is shifting as the FDA approves its first new active ingredient in decades.
The FDA has upgraded a potato chip recall to its highest risk level due to salmonella concerns, affecting popular brands.
The FDA's decision to allow Philip Morris to market ZYN nicotine pouches as safer than cigarettes is sparking debate.
The FDA's top gene therapy regulator is stepping down, amid a significant setback for a kidney disease drug.
FDA staff raise concerns about peptides as advisory panel with proponents of the molecules is announced
The FDA is launching a pilot program to accelerate the review process for new pharmaceutical manufacturing facilities, starting with Eli Lilly and Regeneron.
Major retailers are recalling supplements sold online due to potential salmonella contamination.
Nearly 1 million bottles of heart and kidney medication are being recalled due to a foreign substance found on tablets.
The FDA has upgraded a recall of Utz potato chip varieties to the highest risk level due to salmonella concerns.
New blood-based protein tests are enabling the detection of Alzheimer's and dementia risk decades before clinical symptoms appear.
European regulators are recommending the revocation of marketing authorization for Amgen's autoimmune disease drug, Tavneos.
Gilead's Trodelvy has received broad FDA approval for first-line treatment of triple-negative breast cancer, shifting the landscape away from traditional chemo.
Doctors are increasingly interested in wearable data to inform patient care.
A major recall of popular frozen foods due to plastic contamination has consumers and retailers on alert.
A popular blood pressure medication is under recall due to potential ineffectiveness.
The FDA is launching a pilot program to accelerate early-stage clinical trials to enhance U.S. competitiveness in drug research.
The FDA is reversing its rejection of Regenxbio's gene therapy for Hunter syndrome, marking the third such reversal for rare-disease drugs.
Nearly 375,000 bottles of a popular antidepressant are being recalled due to high levels of a potentially cancer-causing chemical.
The Trump administration is pushing to ease restrictions on testosterone replacement therapy.
An FDA advisory panel has unanimously endorsed Moderna's first-of-its-kind mRNA-based seasonal influenza vaccine, mRNA-1010.